HealthLeaders-InterStudy, a leading provider of managed care industry intelligence, finds that because of its relatively loose certificate-of-need laws, Oklahoma City has become an attractive market for physicians partnering with investors in developing specialty hospitals. According to the latest issue of the Oklahoma City Market Overview, nine physician-owned limited-service hospitals opened between 1994 and 2005.

"The recent opening of McBride Clinic Orthopedic Hospital, yet another Oklahoma City-area physician-owned specialty hospital, reinforces the strength of local competition between physician groups and hospitals for inpatient market share and healthcare dollars," according to Patrick Powers, HealthLeaders-InterStudy senior analyst. "The debate about whether these hospitals are detrimental to the community's local healthcare dynamics continues."

In March 2005, the OU Medical Center provided testimony before the U.S. Senate Committee on Finance showing that the medical center had suffered a major financial loss after nearby Oklahoma Heart Hospital opened in June 2002. OU Medical Center's cardiovascular admissions declined from over 150 patients per month before the heart hospital opened, to zero by August 2002. Cardiovascular physicians from OU Medical Center also left the hospital to become owners in the nearby specialty hospital.

  Other news about the Oklahoma City healthcare market:    * The two largest health plans in Oklahoma City have announced mergers     with national plans, PacifiCare of Oklahoma being acquired by     UnitedHealth Group, Inc., and Blue Cross and Blue Shield of Oklahoma by     Chicago-based Health Care Service Corp., which currently owns Blues     plans in Illinois, Texas, and New Mexico.   * Oklahoma City enrollment in SoonerCare, Oklahoma's Medicaid managed care     program, has increased by five percent since August 2004.    About Market Overviews 

Market Overviews provides a detailed analysis of each local healthcare market, allowing healthcare businesses to plan their local strategies.

About HealthLeaders-InterStudy

HealthLeaders-InterStudy, a company of Decision Resources, Inc. (, is the authoritative source for managed care data, analysis, and news. For more information, please visit

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

  For more information, contact:    Alex Jablokow   Decision Resources   781-296-2562 

SOURCE: HealthLeaders-InterStudy

CONTACT: Alex Jablokow of Decision Resources, +1-781-296-2562,

Cancer Treatment Market for Vascular Endothelial Growth Factor Inhibitors Will Multiply Nearly Ten-Fold to $5.3 Billion by 2009

View Now